Dr Laura Thomas
BSc, PhD
Research Associate
- thomasl41@cardiff.ac.uk
- +44 (0)29 2251 0025 / (0)29 2068 7859
- 1F.08, 1st floor, Cancer Genetics Building, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN
- Media commentator
- Available for postgraduate supervision
Overview
As part of the Inherited Tumour Syndrome Research Group, I have a particular interest in intestinal polyposis syndromes, specifically polyposis of the duodenum and colorectum. The aim of my research is to develop new methods and techniques for mutation detection and to characterise inherited and somatic genetic mechanisms in patients with inherited tumour syndromes.
Biography
Publications
We are currently unable to retrieve the list of publications. Visit our institutional repository.My research interests involve the use of high throughput genomic technologies to determine the molecular mechanisms underlying rare genetic disorders and tumour predisposition syndromes.
My research is funded by a Health and Care Research Wales Fellowship.
Research studies in which I am currently involved include:
Molecular genetic analysis of duodenal polyposis in the inherited colorectal adenoma and cancer predisposition syndromes (Familial Adenomatous Polyposis and MUTYH-Associated Polyposis) (15/WA/0075. CRNCC ID, 19065) [Chief Investigator]
Genetic mechanisms in polyposis of the bowel (12/WA/0071. CRNCC ID, 14774)
A Prospective Europe-Wide Study of Duodenal Disease in MUTYH-Associated Adenomatous Polyposis (MAP).(11/WA/0208)
Exome/genome sequencing of TSC no mutation identified (NMI) patients (11/WA/0276. CRNCC ID, 13635) tuberous-sclerosis.org/take-part-in-research
Supervision
Past projects
Current research students:
- Emma Short, PhD (2013-2018)
- 'Genetic mechanisms in polyposis of the bowel'
- Elena Meuser, PhD (2015-2018)
- 'Molecular mechanisms of tumorigenesis in familial polyposis syndromes'
Previous students:
- Joanna Hurley, MD (2012-2015)
- 'Molecular genetic and endoscopic studies of duodenal polyposis in the inherited colorectal adenoma and cancer predisposition syndromes (Familial Adenomatous Polyposis and MUTYH-Associated Polyposis)'